Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 46,617 | 44,860 | 58,234 | 48,000 | 49,693 |
| Cost of Goods | 21,181 | 21,847 | 25,186 | 20,822 | 21,531 |
| Gross Profit | 25,436 | 23,013 | 33,048 | 27,178 | 28,162 |
| Operating Expenses | 34,144 | 34,594 | 33,370 | 34,420 | 37,820 |
| Operating Income | -8,527 | -10,734 | -136 | -6,420 | -9,127 |
| Interest Expense | 134 | 441 | 394 | 595 | 409 |
| Other Income | 1,475 | 2,182 | 4,641 | 2,830 | 2,941 |
| Pre-tax Income | -7,186 | -8,993 | 4,111 | -4,185 | -6,595 |
| Income Tax | 3,248 | -2,824 | -1,392 | 2,271 | -2,207 |
| Net Income Continuous | -10,434 | -6,169 | 5,503 | -6,456 | -4,388 |
| Net Income | $-10,434 | $-6,169 | $5,503 | $-6,456 | $-4,388 |
| EPS Basic Total Ops | -0.08 | -0.05 | 0.04 | -0.05 | -0.03 |
| EPS Basic Continuous Ops | -0.08 | -0.05 | 0.04 | -0.05 | -0.03 |
| EPS Diluted Total Ops | -0.08 | -0.05 | 0.04 | -0.05 | -0.03 |
| EPS Diluted Continuous Ops | -0.08 | -0.05 | 0.04 | -0.05 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.05 | 0.04 | N/A | N/A |
| EBITDA(a) | $-6,047 | $-8,274 | $2,289 | $-3,861 | $-6,682 |